BREATHING CONVERSATIONS
When Politics Gets into Pulmonology: How Public Decisions Influence Respiratory Health
March 30, 2026
Excellence in Respiratory Medicine
Innovation and research for respiratory health
Scientific insights, clinical updates and perspectives on respiratory disease care.
It is more important to know which person has which disease than which disease a person has.
Professional profile
Doc. Luca Richeldi
Institution
Agostino Gemelli University Hospital IRCCS
Respiratory medicine is a complex, ever-evolving discipline, grounded in data, method and responsibility.
In this space I wish to share knowledge, clinical experiences and reflections developed through years of research and working alongside patients.
I believe in transparent, verifiable science that is open to discussion. I believe that methodological rigour is the only true safeguard against the noise of opinions. I believe that a doctor's professionalism is built through time, results, study and consistency.
This blog was created to explain, clarify and explore the topics of respiratory medicine in an accessible language, yet grounded in evidence.
Here, scientific data and the patient come first.
Because protecting breath means protecting life.
Respiratory medicine is the science of data, but above all the care of people who live every day with the fragility of breath.
Professional experience
Appointments & roles
Highlights of key academic and institutional roles.
2006–2013
Honorary Consultant in Respiratory Medicine, University Hospital of Modena, Modena (Italy).
2007–2013
Director, Centre for Rare Lung Diseases, University Hospital of Modena (Italy).
1997–2005
Consultant in Respiratory Medicine, Policlinic Hospital of Modena (Italy).
1993–1996
Ph.D. student, University of Rome La Sapienza (Italy).
1990–1993
Research Fellow, University of Rome La Sapienza (Italy).
1988
Degree in Medicine from the University of Modena (Italy) and professional qualification as surgeon.
Recent articles
TEACHING, RESEARCH AND DISCLOSURE
AI and Pulmonary Fibrosis: New Paths to IPF Prognosis
March 30, 2026
ENVIRONMENT AND LUNGS
Asthma and pollution: why personal monitoring can change clinical perspective
March 30, 2026
ENVIRONMENT AND LUNGS
The environment, public policy and respiratory health: why public policy decisions affect our lungs
March 27, 2026
ENVIRONMENT AND LUNGS
Forest fires and respiratory health: a growing risk in the age of climate change
March 26, 2026
TEACHING, RESEARCH AND DISCLOSURE
The Teton-2 Study: a new therapeutic approach to idiopathic pulmonary fibrosis
March 24, 2026